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Objective: To observe the clinical effect of a modified Simiao Tang (加味四妙汤Modified Decoction of 
Four Wonderful Drugs) for gouty arthritis and its influence on uric acid in blood. Methods: 120 cases of 
gouty arthritis were randomly divided into the treatment group and control group with 60 cases in each group. 
Modified Simiao Tang (MST) was orally administered to the patients in the treatment group and allopurinol 
tablet was orally administered to the patients in the control group. The clinical effects of two groups were 
evaluated after one-week treatment and uric acid (UA) and C-reactive protein (CRP) levels in blood were 
determined after 1-month treatment. Results: The total effective rate in the treatment group was significantly 
higher than in the control group, 86.7% vs. 68.3% (P< 0.01). And the treatment group was also significantly 
better than the control group in decreasing UA and CRP (P< 0.05 or P< 0.01). Conclusions: MST can 
significantly improve the symptoms and signs of gouty arthritis and decrease the levels of UA and CRP. It is 
good for gouty arthritis. 
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Gouty arthritis is a disease characterized by redness, 
swelling and pain of joints, limited articular motion 
and dysfunction, and repeated attacks. It is caused by 
uratic deposition in the articular cavity or soft tissues 
due to hyperuricemia resulting from purine metabolic 
disturbance. In recent years it was found that this 
disease was accompanied with obesity, hyperlipemia, 
diabetes and high blood pressure, formed the 
syndrome of metabolism, which was caught much 
attention in clinic. The effect of western medications 
is definite during the acute onset, yet the side effects 
of serious gastrointestinal stimulation, injuries of the 
liver and kidney and arrest of marrow limit its 
clinical application. The 60 cases of gouty arthritis 
were treated with a modified Simiao Tang from 2003 
to observe its clinical effect and adjusting function on 
uric acid (UA). A comparison was made with the 60 
cases in the control group treated by allopurinol 
tablets. The report is as follows.  
CLINCAL DATA 
The 120 patients in this series were the outpatients of 
Rheumatic Department in Shenzhen Longgang 
Central Hospital from February 2003 to February 
2007 and randomly divided into two groups. There 
were 60 cases in the treatment group, including 56 
males and 4 females, aged 30–64 years (mean, 
46.90±3.37), with duration of illness 1–10 years 
(mean, 3.70±1.68). Of them, 10 cases were an initial 
onset, 24 cases the second onset and 26 cases the 
multiple onsets. There were 60 cases in the control 
group, including 57 males and 3 females, aged 31–63 
years (mean, 46.80±3.24), with the duration of illness 
1–9 years (mean, 3.60±1.59). Of them, 8 cases were 
an initial onset, 25 cases the second onset and 27 
cases the multiple onsets. There was no significant 
difference of the general data in the two groups after 
statistic analysis (P>0.05), therefore, being 
comparable. 
Diagnostic criteria 
Inclusive criteria: Classified Criteria for Gouty 
Arthritis by American Society of Rheumatism in 1997 
and the Diagnostic Criteria for Gout in Guiding 
Principles for Clinical Research on New drugs of 
Chinese Medicine issued by the Pharmaceutical 
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Bureau of Health Ministry of China in 1993 were 
followed.1, 2 
Exclusive criteria: 1) Those with functional in- 
sufficiency of the heart, lung, liver, and kidney. 2) 
Those with an age over 70 year. 3) Those with severe 
deformation and stiffness of joints in late stage and 
those with loss of labor ability. 
METHODS 
MST was administered to patients in the treatment 
group. The formula consisted of Huang Bai (黄柏
Cortex Phellodendri) 15g, Cang Zhu (苍术 Rhizoma 
Atractylodis) 15g, Yi Yi Ren (薏苡仁 Semen Coicis) 
30g, Niu Xi (牛膝Radix Achyranthis Bidentatae) 15g, 
Ren Dong Teng (忍冬藤 Caulis Lonicerae) 30g, Tu 
Fu Ling (土茯苓Rhizoma Smilacis Glabrae) 30g, Zhi 
Mu (知母 Rhizoma Anemarrhenae) 15g, Chi Shao 
(赤芍 Radix Paeoniae Rubra) 10g, Wei Ling Xian (威
灵仙 Radix Clematidis) 15g, Mian Bi Xie (棉萆薢
Rhizoma Dioscoreae Septemlobae) 15g, Ze Xie (泽
泻 Rhizoma Alismatis) 10g and Wu Shao She (乌梢
蛇 Zaocys) 15g. They were decocted in water and 
taken orally one dose each day, in the morning and 
evening respectively. Allopurinol tablet (produced by 
Shanghai Xinyi Wanxiang Pharmaceutical Company 
Ltd., Permission Number of the National Drugs 
H310200334, 0.1g per tablet) were given to patients 
in the control group in a dose of one tablet two times 
daily after meal. The therapeutic course for the two 
groups was 1 month. Other analgesics and the drugs 
interfering with the UA were contraindicated during 
the treatment.  
Observation method 
Clinical effect: The criteria for swelling and pain in 
the joints were in accordance with An Assemblage of 
Guiding Principles of Clinical and Pre-clinical 
Research on New Drugs (Western Drugs). 3  
Observed indices: 1) The score of the patients of two 
groups was recorded before treatment and 1 week 
after starting treatment. 2) Blood and urine routine 
examinations and function tests of liver and kidney 
were performed and UA and C-reactive protein (CRP) 
levels in blood were determined before treatment and 
1 month after starting treatment. 3) Safety was 
evaluated.  
Statistics methods 
Χ
2
 test was used for enumeration data and t test for 
measurement data.  
RESULTS 
The criteria for therapeutic effect were worked out 
according to An Assemblage of Guiding Principles of 
Clinical and Pre-clinical Research on New Drugs 
(Western Drugs). 3 Clinical cure: The index of 
swelling and pain in the joints within 1 week was 
decreased by ≥75%; Markedly improved: The index 
of swelling and pain in the joints within 1 week was 
decreased by 50%–74%; Improved: The index of 
swelling and pain in the joints within 1 week was 
decreased by 30%–49%; Ineffective: The index of 
swelling and pain in the joints within 1 week was 
decreased by < 30%. 
The index of swelling and pain in the joints = (total 
scores of swelling and pain in the joints before 
treatment — total scores of swelling and pain in the 
joints after treatment) / total scores of swelling and 
pain in the joints before treatment×100%. Total 
scores of swelling and pain in the joints = score of 
pain in the joints during rest + score of tenderness + 
score of swelling and distension in the joints. 
Comparison of the therapeutic effect between the 
two groups 
Table 1 showed that among the 60 cases in the 
treatment group 19 cases (31.7%) was cured, 22 
cases (36.6%) markedly improved, 11 cases (18.3%) 
improved, and 8 cases (13.3%) ineffective, total 
effective rate was 86.7%. Among the 60 cases in the 
control group 9 cases (15.0%) were cured, 13 cases 
(21.7%) markedly improved, 19 cases (31.7%) 
improved, and 19 cases (31.7%) ineffective, total 
effective rate was 68.3%. The effective rate in the 
treatment group was better than that in the control 
group (P<0.01). 
Comparison of the changes of UA and CRP in the 
two groups 
Table 2 showed that there were significant 
differences in UA and CRP levels before and after 
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treatment in the treatment group (P<0.05 or P<0.01). 
There was significant difference in UA level before 
and after treatment in the control group (P<0.01). 
There was significant difference after treatment 
between the two groups (P<0.05 or P<0.01). The 
therapeutic effect in the treatment group was much 
better than that in the control group. 
Safety evaluation 
No significant side effect or reaction was found after 
taking MST.
Table 1. Comparison of clinical effect between the two groups 
Groups Cases Cure Markedly improved Improved Ineffective Total effective rate (%) 
Treatment group 60 19 22 11  8 86.7 
Control group 60  9 13 19 19 68.3 
Table 2. Comparison of changes in UA and CRP levels before and after treatment ( x ±s) 
Groups Cases  UA (µmol/L) CRP (mg/L) 
Treatment group 60 Before treatment 545.23±63.35 15.37±9.34 
  After treatment    412.11±61.76*△     7.65±8.91**△△ 
Control group 60 Before treatment 538.67±62.19 16.12±9.52 
  After treatment  461.70±63.51* 12.32±9.11 
Compared with the group before treatment * P<0.05, ** P<0.01, compared with the control group at the  
same time △P<0.05,△△P<0.01. 
DISCUSSION 
The primary gout belongs to a heterogeneous disease 
due to uric acid metabolic abnormity with its cause 
unknown. It may be the genetic disease of multiple 
genes, is often induced by intake of foods rich in 
purine such as meat and seafood and accompanied 
with obesity, diabetes, hyperlipemia and hypertension. 
The hyperuricemia of primary gout is mainly caused 
by excretory disturbance of uric acid. Chen Ying et al 
pointed out that a decrease in uric acid excretion 
occupied 90% of hyperuricemia, eg. a reduction in 
uric acid filtered off from the glomerulus and a 
reduction in uric acid excreted from the renal tubules 
and/or an increase in reabsorption of uric acid, all 
resulted in the decreased uric acid excretion, thus 
hyperuricemia occurred. 4 
The main clinical manifestations of gouty arthritis are 
redness, swelling, heat and pain in the affected joints 
and the motion disturbance. It belongs to heat 
arthralgia or agonizing arthralgia of arthralgia in 
traditional Chinese medicine. The etiology and 
mechanism are thought to have a relation with 
phlegm, blood stasis, damp and toxic heat. It is due to 
excessive intake of greasy and sweet food or 
excessive drinking of wine, later damp and phlegm 
produced and turned to heat. The damp, heat and 
phlegm flowed downward and blocked the channels 
and collaterals in the joints, resulting in pain due to qi 
and blood obstruction, thus redness, swelling, heat 
and pain in the joints of feet and ankles. The joints 
will have varying degrees of destruction of bones and 
functional disorders if the gouty arthritis frequently 
flares up. 
Huang Bai (黄柏 Cortex Phellodendri), Cang Zhu (苍
术 Rhizoma Atractylodis), Yi Yi Ren (薏苡仁 Semen 
Coicis) and Niu Xi (牛膝 Radix Achyranthis 
Bidentatae) are the ingredients of the original formula 
of Simiao San (四妙散 Powder of Four Wonderful 
Drug). Huang Bai (黄柏 Cortex Phellodendri) has the 
function of clearing heat, expelling damp and fire and 
removing toxicity. It acts on the lower Jiao. Cang Zhu 
(苍术 Rhizoma Atractylodis) having the therapeutic 
action on the spleen and stomach can internally expel 
the damp in the spleen and expel the external damp 
as well. These two herbs are the key herbs to treat 
arthralgia due to damp and heat. Yi Yi Ren (薏苡仁
Semen Coicis) can clear heat and remove damp, 
strengthen the spleen and relax muscles and tendons. 
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Niu Xi (牛膝 Radix Achyranthis Bidentatae) can 
tonify the liver and kidney, strengthen the bone and 
muscles, expel the wind-damp and guide the other 
drugs down to the affected part. A combination of the 
four herbs is a common formula to treat the redness, 
swelling, heat and pain in the joints of feet and ankles 
due to damp-heat in the lower limbs and the 
symptoms of flaccidity and numbness. On the basis 
of Simaio San (四妙散 Powder of Four Wonderful 
Drugs), Ren Dong Teng (忍冬藤 Caulis Lonicerae) 
added is to expel heat, remove toxicity, dredge 
collaterals and relieve pain in the muscles and bones. 
Wu Shao She (乌梢蛇 Black-tailed Snake, Zaocys) is 
good for expelling dampness, relaxing muscles and 
bones and clearing collaterals and is the key herb for 
arthralgia due to damp. Mian Bi Xie (棉萆薢
Rhizoma Dioscoreae Septemlobae) and Tu Fu Ling 
(土茯苓 Rhizoma Smilacis Glabrae) can expel wind 
and remove damp and are good at expelling 
wind-damp and treating severe arthralgia. Zhi Mu (知
母Rhizoma Anemarrhenae) and Wei Ling Xian (威灵
仙 Radix Clematidis) can clear heat and dry damp 
and treat arthralgia. Ze Xie (泽泻 Rhizoma Alismatis) 
can remove damp turbidity. Chi Shao (赤芍 Radix 
Paeoniae Rubra) can tonify blood and soften tendons, 
in combination with Niu Xi (牛膝 Radix Achyranthis 
Bidentatae) promote the blood circulation to remove 
blood stasis and increase excretion of uric acid in the 
blood. The whole formula plays the role of clearing 
heat, dredging the collaterals, stopping pain and 
removing damp, thus the therapeutic effect is 
obtained. The modern pharmacology shows that Wei 
Ling Xian (威灵仙 Radix Clematidis) may increase 
excretion of uric acid and decrease uric acid content 
in the blood and has the significant function of 
stopping pain. Mian Bi Xie (棉萆薢 Rhizoma 
Dioscoreae Septemlobae), Tu Fu Ling (土茯苓
Rhizoma Smilacis Glabrae), Yi Yi Ren (薏苡仁
Semen Coicis) and Ze Xie (泽泻 Rhizoma Alismatis) 
may also increase excretion of uric acid and decrease 
uric acid content in the blood. Niu Xi (牛膝 Radix 
Achyranthis Bidentatae) has the function of protein 
assimilation, decreasing absorption of lipid, 
preventing the lipids from retaining in the serum or 
penetrating to the lining of the artery, changing the 
metabolism of lipid and purine, thus the aim of 
decreasing lipid and uric acid in the blood is 
obtained5. 
This research indicated that the modified Simiao Tang 
may effectively improve the symptoms and signs of 
gouty arthritis, significantly decrease UA and CRP 
and adjust the disordered metabolism of human body 
with no side effects, worth popularizing and further 
exploring. 
REFERENCES 
1. 熊曼琪, 邓兆智. 内分泌科专病与风湿病中医临床诊
断. 北京: 人民卫生出版社 2000; 273. 
2. 中华人民共和国卫生部. 中药新药临床研究指导原则
(第二辑). 1995; 179-183. 
3. 中华人民共和国卫生部药政局. 新药(西药)临床及临
床前沿就指导原则汇编. 1993; 107-112. 
4. 陈颖, 李长贵, 苗志敏. 原发高尿酸血症发病机制研
究进展. 国际遗传杂志 2006; 29 (1): 59-65. 
5. 董琦燕. 牛膝治疗高尿酸血症告知血证. 辽宁中医杂
志 2003; 30 (11): 943. 
(Translated by Zhu Hanting朱函亭) 
 
